Open AccessLipid Nanoparticles Delivery of CRISPR/Cas9 Targeting PCSK9 and ANGTPL3 as New Therapeutic Gene Editing Modalities for Potential Long-Lasting Treatment Of Dyslipidemia
Author(s) -
Ramidha Syaharani,
Fauziah Adhima,
Sarah Nia Amru,
Reny I’tishom
Publication year - 2021
Publication title -
international journal of research publications
Language(s) - English
Resource type - Journals
ISSN - 2708-3578
DOI - 10.47119/ijrp100921120222750
Subject(s) - pcsk9 , crispr , dyslipidemia , genome editing , medicine , cas9 , proprotein convertase , bioinformatics , cholesterol , biology , lipoprotein , ldl receptor , disease , gene , genetics